TOP TIERMARKET NEWSWIRE
News & sentiment

MEREO BIOPHARMA GROU ADR (MREO) — News & AI sentiment

MEREO BIOPHARMA GROU ADR (MREO) news roundup. 7 stories in the last 24 hours, 7 in the past week, 7 over 30 days. Average 24-hour sentiment is 51.9/100 — neutral (50 is neutral). No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
7
avg sentiment 51.9/100
7d stories
7
avg sentiment 51.9/100
30d stories
7
avg sentiment 51.9/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

MREO news in the last 24 hours, 7 days, 30 days and 90 days

How much MREO coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowMREO storiesAvg AI sentimentRead
Last 24 hours751.9/100MREO headlines →
Last 7 days751.9/100MREO headlines →
Last 30 days751.9/100MREO headlines →
Last 90 days751.9/100MREO headlines →

Latest stories on MREO

4h ago
4h ago
Mereo BioPharma Group GAAP EPS of -$0.01 in-line
Seeking Alpha56 · neutralearnings
5h ago
5h ago
5h ago
5h ago
5h ago
Open MREO in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →